Efficacy and safety of topical calcitriol 3 μg/g ointment, a new topical therapy for chronic plaque psoriasis

Journal of Drugs in Dermatology

Volumn 8, Issue 8, 2009, Pages

  Kircik, Leon ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CALCITRIOL; CALCIUM; MINERAL OIL; WHITE PETROLATUM; VITAMIN;

APPLICATION SITE ERYTHEMA; APPLICATION SITE IRRITATION; APPLICATION SITE PRURITUS; APPLICATION SITE REACTION; ARTICLE; BODY SURFACE; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHEMA; HUMAN; HYPERCALCEMIA; MONOTHERAPY; OINTMENT; OUTCOME ASSESSMENT; PSORIASIS VULGARIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKIN DISCOMFORT; SKIN PENETRATION; SKIN PRURITUS; TOPICAL TREATMENT; TREATMENT RESPONSE; XERODERMA; CHRONIC DISEASE; HOMEOSTASIS; METABOLISM; PATHOLOGY; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; CALCITRIOL; CALCIUM; CHRONIC DISEASE; HOMEOSTASIS; HUMANS; OINTMENTS; PSORIASIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMINS;

EID: 70149122440     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Pearce DJ, Stealey KH, Balkrishnan R, et al. Psoriasis treatment in the United States at the end of the 20th century. Int J Dermatol. 2006;45(4):370-374.
2. Nagpal S, Lu J, Boehm MF. Vitamin D analogs: Mechanism of action and therapeutic applications. Curr Med Chem. 2001;8(13):1661-1679. (Pubitemid 33076807)
3. British Association of Dermatologists. Clinical Guidelines. Topical Vitamin D Analogues. Available at: http://www.bad.org.uk/healthcare/guidelines/ psorvitamin.asp. Accessed March 9, 2009.
4. Veien NK, Bjerke JR, Rossmann-Ringdahl I, Jakobsen HB. Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial. Br J Dermatol. 1997;137(4):581-586. (Pubitemid 27469510)
5. Rizova E, Corroller M. Topical calcitriol - Studies on local tolerance and systemic safety. Br J Dermatol. 2001;144 Suppl 58:3-10.
6. Vectical (calcitriol) ointment 3 mcg/g [prescribing information]. Fort Worth, TX: Galderma Laboratories; 2009.
7. Marty JP, Lafforgue C, Grossiord JL, Soto P. Rheological properties of three different vitamin D ointments and their clinical perception by patients with mild to moderate psoriasis. J Eur Acad Dermatol Venereol. 2005;19 Suppl 3:7-10. (Pubitemid 41726919)
8. Queille-Roussel C, Duteil L, Parneix-Spake A, et al. The safety of calcitriol 3 microg/g ointment. Evaluation of cutaneous contact sensitization, cumulative irritancy, photoallergic contact sensitization and phototoxicity. Eur J Dermatol. 2001;11(3):219-224. (Pubitemid 32472673)
9. Lebwohl M, Menter A, Weiss J, et al. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: Results from 2 placebo-controlled, multicenter, randomized doubleblind, clinical studies. J Drugs Dermatol. 2007;6(4):428-435.
10. Bourke JF, Iqbal SJ, Hutchinson PE. A randomized double-blind comparison of the effects on systemic calcium homeostasis of topical calcitriol (3 micrograms/g) and calcipotriol (50 micrograms/g) in the treatment of chronic plaque psoriasis vulgaris. Acta Derm Venereol. 1997;77(3):228-230. (Pubitemid 27240196)
11. Kowalzick L. Clinical experience with topical calcitriol (1,25-dihy-droxyvitamin D3) in psoriasis. Br J Dermatol. 2001;144 Suppl 58:21-25. (Pubitemid 33756011)
12. Carboni I, de Felice C, Bergamin A, Chimenti S. Topical use of calcitriol 3 microg/g ointment in the treatment of mild-to-moderate psoriasis: Results from an open-label study. J Eur Acad Dermatol Venereol. 2005;19 Suppl 3:11-13. (Pubitemid 41726920)
13. Barker JN, Berth-Jones J, Groves R, et al. Calcium homeostasis remains unaffected after 12 weeks' therapy with calcitriol 3 microg/g ointment; No correlation with extent of psoriasis. J Dermatolog Treat. 2003;14(1):14-21. (Pubitemid 36417422)
14. Langner A, Ashton P, Van De Kerkhof PC, Verjans H. A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis. Br J Dermatol. 1996;135(3):385-389. (Pubitemid 26297832)
15. Lebwohl M, Ortonne JP, Andres P, Briantais P. Calcitriol 3 ointment microg/g is safe and effective over 52 weeks for the treatment of mild to moderate plaque psoriasis. Cutis. 2009;83(4):205-212.
16. Morrison A, Mizzi F. Multicenter, open-label, non comparative long term safety study to assess the local and systemic safety of calcitriol 3 μg/g ointment applied twice daily for up to 52 weeks in subjects suffering from mild to moderate chronic plaque psoriasis. Galderma Research & Development; 2004 Jun. Study Report RD.03.SRE.2663.